HeartBeat.bio
HeartBeat.bio is a privately funded drug discovery company focusing on the development of a high-throughput 3D screening platform.
HeartBeat.bio is a business in biotechnology, medical based in European Union (EU), Europe, Middle East, and Africa (EMEA), founded in 2021.
The company sits in the biotechnology, medical segment, where it competes on its core product or service.
Its base of operations is European Union (EU), Europe, Middle East, and Africa (EMEA).
It is recorded at the Seed stage.
The company reports a headcount in the c_00011_00050 range.
It has disclosed roughly $6M in funding.
| Sector | Biotechnology, Medical |
|---|---|
| Headquarters | European Union (EU), Europe, Middle East, and Africa (EMEA) |
| Founded | 2021 |
| Employees | c_00011_00050 |
| Stage | seed |
| Total funding | $6,000,000 |
Website: heartbeat.bio
Browse related
Contact details and direct channels are available to signed-in members.
Create a free account
Create a free account